Tag:
Orchid Cellmark
Latest Headlines
Latest Headlines
C&L: Somnus names executive team
Gary Cupit, PharmD, has been named CEO of Somnus Therapeutics. The rest of the executive team: Mary Osbakken, MD, PhD, chief medical officer; Christine Blumhardt, PharmD, chief regulatory officer;
